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A new regulatory framework 
will in January 2016 enable 
medical schemes to offer 
low-cost, limited-benefit 
pri mary care medical aid, 
expanding private healthcare coverage 
by an extra 12.7 million people (from the 
current decade-long-stagnant 8.7 million 
higher-income members).
It’s being touted as a potential trigger for 
private health access reform, complementing 
the impending National Health Insurance 
aimed at more equitable healthcare access 
for the other 84% of the population, most 
of whom depend on the overloaded, often 
dysfunctional public sector. Paresh Prema, 
Head of Benefit Management at the Council for 
Medical Schemes (CMS) and Johan Pretorius, 
CEO of Universal Health, told the Board of 
Healthcare Funders annual conference in 
Cape Town this July that the key to keeping 
low-income benefit option costs down lay 
in having healthcare provider networks that 
charged agreed-upon rates. Pretorius proposed 
to the CMS guideline architects that scheme 
members so covered should fall below the tax 
threshold (R5 296 per month). The CMS is 
considering restricting membership of the low-
cost options to people with an income below 
R6 000 a month (but possibly up to R12 000), 
or prohibiting members from moving from 
more expensive options to the new low-cost 
options and/or limiting membership to those 
who have not been a member of a scheme 
before. The hope is also that not offering 
full private hospital cover will deter some 
members of more expensive options from 
moving to them or ‘buying down’. The Council 
is also reviewing a proposal to exempt the 
new options from having to hold reserves 
equal to 25% of contributions. Pretorius said 
administrators of medical schemes had proved 
that it cost more to provide membership to 
individuals than to groups.
Marrying cost-efficiency 
with decent benefits
At its August 2015 sitting, the CMS 
approved the exemption framework and 
principles allowing for the introduction and 
registration of low-cost benefit options in 
the medical schemes industry effective from 
1 January 2016 – in an attempt to marry cost 
efficiency with decent benefits. Prema said 
that the guidelines for exemption from the 
Act were drawn up after consultation with 
two scheme administrators, two medical aid 
schemes and some specialist provider groups 
and would be published soon after approval 
by the CMS’s 13-member governing board. 
This should enable schemes to get their 
low-income options in place by January next 
year. However, individual schemes would 
first have to make their submissions to the 
CMS for approval based on the exemption 
guidelines. Delays might occur, because 
most schemes would simultaneously be 
planning their overall benefits for next year.
Each of the 12 guideline submissions from 
the industry had laid out the costs of two 
primary care options. The most basic offered 
three GP visits, basic dentistry and optometry, 
and basic pathology and radiology services 
– but no emergency or private hospital care.
The benefits were based on feedback from
households surveyed a decade ago in research
commissioned by the CMS. Sacrificed on the
altar of cost-efficiency are prescribed minimum 
benefits (PMBs), an extensive set of medical
conditions, chronic diseases and emergency
care that the Medical Schemes Act says must
otherwise be provided by all medical schemes.
Costs of PMBs rising
Pretorius said it cost schemes R508 per 
person per month to provide cover for PMB 
benefits in 2013, a figure he estimates has 
risen to about R600 per month. 
Prema said of the guidelines his team have 
drawn up: ‘It will motivate the exceptional 
case for all schemes. It’s around affordability. 
We want to simplify it so that schemes know 
what is expected when they apply – and it’s 
entirely around primary healthcare products,’ 
he explained. One idea was to see if it was cost-
effective to have higher minimum benefits: 
‘We don’t want it to be too onerous to [prevent 
it] reach[ing] the target market.’ The original 
lower-income medical schemes survey was 
done in 2005, so subsequent salary hikes and 
inflation needed to be taken into account 
to avoid running the risk of prescribing a 
minimum benefit not valued by the market. 
‘We’re hoping that specialties like radiology 
and pathology will buy into it and provide 
benefits at a lower cost, because they realise 
that this is aimed at a lower-income market. 
It’ll take time for everybody to buy into – that’s 
why the exemption process is a good start.’ He 
said that the generic benefit package being 
proposed was ‘more about what the benefits 
are and not what diseases are covered’. ‘We 
have to change the way in which we sell 
or structure this product to deal with what 
benefits will be used. It doesn’t make sense to 
have a PMB package covering 270 conditions 
at a cost that is unaffordable – and not dealing 
with the immediate needs.’ Asked to elaborate 
on the ‘package’, he said it would deal with 
the day-to-day immediate needs of members 
such as consultations and acute and chronic 
medications. ‘It’s what people in the market 
are willing to pay for to avoid a [public sector] 
queue or miss a day’s work.’ The idea was to 
help schemes grow their memberships and 
increase access to healthcare.
Only about one million medical scheme 
members (10.87% of total lives covered) 
currently belong to low-cost options that 
offer benefits via provider networks. 
Pretorius called on providers to offer more 
low-cost services that could be included in 
the new options, suggesting that the Council 
might consider allowing schemes to restrict 
membership of the low-cost options to 
people who live in areas where there were 
provider networks to service them.
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Prema said the guidelines for 
exception from the Act were 
drawn up after consultation 
with two scheme administrators, 
two medical aid schemes and 
some specialist provider groups 
and would be published soon 
after approval by the CMS’s 
13-member governing board.
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